Pedro Enrique Dorlhiac-Llacer
Overview
Explore the profile of Pedro Enrique Dorlhiac-Llacer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mendrone Jr A, Sabino E, Sampaio L, Almeida Neto C, Schreiber G, Chamone D, et al.
Transfusion
. 2009 Jan;
49(4):662-8.
PMID: 19171005
Background: Anemia screening before blood donation requires an accurate, quick, practical, and easy method with minimal discomfort for the donors. The aim of this study was to compare the accuracy...
12.
de Mello Conchon M, Bendit I, Ferreira P, Lima W, Kumeda C, Dias L, et al.
Int J Hematol
. 2008 Dec;
89(1):123-125.
PMID: 19093165
No abstract available.
13.
de Conchon M, Costa J, Novaes M, Dorlhiac-Llacer P, Chamone D, Bendit I
Int J Hematol
. 2008 Jul;
88(2):243-245.
PMID: 18626727
No abstract available.
14.
Pereira J, Bellesso M, Pracchia L, Hallack Neto A, Beitler B, Macedo M, et al.
Leuk Res
. 2005 Nov;
30(6):681-5.
PMID: 16288806
Background: The purpose of this retrospective study was to investigate the efficacy, toxicity and mobilization rate after modified Magrath IVAC (mIVAC) chemotherapy regimen prescribed in relapsed disease (RD) or primary...
15.
Pracchia L, Santos Dias L, Dorlhiac-Llacer P, de Alencar Fisher Chamone D
Rev Hosp Clin Fac Med Sao Paulo
. 2004 Nov;
59(5):291-5.
PMID: 15543402
Purpose: Infection is the leading complication of long-term central venous catheters, and its incidence may vary according to catheter type. The objective of this study was to compare the frequency...
16.
Novaretti M, Jens E, Pagliarini T, Bonif cio S, Dorlhiac-Llacer P, Chamone Dd D
Rev Hosp Clin Fac Med Sao Paulo
. 2004 Feb;
58(6):320-3.
PMID: 14762491
Anti-U is a rare red blood cell alloantibody that has been found exclusively in blacks. It can cause hemolytic disease of the newborn and hemolytic transfusion reactions. We describe the...
17.
Novaretti M, Fonseca G, Conchon M, Dorlhiac-Llacer P, Chamone D
Eur J Haematol
. 2004 Jan;
71(6):455-8.
PMID: 14703696
Imatinib mesylate is a specific inhibitor of protein tyrosine kinase activity secondary to bcr-abl, mostly indicated for the treatment of patients with Philadelphia chromosome positive chronic myeloid leukaemia (CML). Generally,...